Shares of cannabis company Curaleaf Holdings Inc. slid 7% Tuesday, after the U.S. Food and Drug Administration issued a warning letter to the company for...
View full coverage on Google NewsCuraleaf shares tumble 8% after FDA sends warning letter over CBD health claims - MarketWatch
Read More
Bagikan Berita Ini
0 Response to "Curaleaf shares tumble 8% after FDA sends warning letter over CBD health claims - MarketWatch"
Post a Comment